A detailed history of Ubs Group Ag transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Ubs Group Ag holds 29,876 shares of RGLS stock, worth $47,502. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,876
Previous 19,217 55.47%
Holding current value
$47,502
Previous $34,000 35.29%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.46 - $1.9 $15,562 - $20,252
10,659 Added 55.47%
29,876 $46,000
Q2 2024

Aug 13, 2024

BUY
$1.79 - $2.8 $33,857 - $52,962
18,915 Added 6263.25%
19,217 $34,000
Q1 2024

May 13, 2024

SELL
$1.13 - $2.88 $47 - $120
-42 Reduced 12.21%
302 $0
Q4 2023

Feb 09, 2024

SELL
$1.21 - $1.44 $77 - $92
-64 Reduced 15.69%
344 $0
Q3 2023

Nov 09, 2023

SELL
$1.27 - $1.76 $4,069 - $5,639
-3,204 Reduced 88.7%
408 $0
Q2 2023

Aug 11, 2023

BUY
$0.87 - $1.75 $1,630 - $3,279
1,874 Added 107.83%
3,612 $5,000
Q1 2023

May 12, 2023

SELL
$0.79 - $1.61 $3,099 - $6,317
-3,924 Reduced 69.3%
1,738 $1,000
Q4 2022

Feb 08, 2023

SELL
$1.17 - $1.85 $5,281 - $8,350
-4,514 Reduced 44.36%
5,662 $7,000
Q3 2022

Nov 10, 2022

BUY
$1.35 - $2.39 $2,597 - $4,598
1,924 Added 23.32%
10,176 $17,000
Q2 2022

Aug 10, 2022

BUY
$1.6 - $3.4 $13,203 - $28,056
8,252 New
8,252 $17,000

Others Institutions Holding RGLS

About Regulus Therapeutics Inc.


  • Ticker RGLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,634,400
  • Market Cap $23.3M
  • Description
  • Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...
More about RGLS
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.